This Metric Says You Are Smart to Buy ISIS Pharmaceuticals, Inc. (ISIS)

Page 1 of 2

Is ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) worth your attention right now? Investors who are in the know are taking an optimistic view. The number of bullish hedge fund bets advanced by 9 in recent months.

In the financial world, there are dozens of indicators investors can use to watch Mr. Market. A couple of the most underrated are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best money managers can outperform the S&P 500 by a solid amount (see just how much).

Equally as integral, optimistic insider trading activity is another way to parse down the stock market universe. Just as you’d expect, there are many incentives for a corporate insider to downsize shares of his or her company, but only one, very simple reason why they would initiate a purchase. Many academic studies have demonstrated the impressive potential of this strategy if piggybackers understand what to do (learn more here).

Consequently, let’s take a gander at the key action regarding ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS).

What have hedge funds been doing with ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)?

In preparation for this quarter, a total of 14 of the hedge funds we track were long in this stock, a change of 180% from one quarter earlier. With the smart money’s capital changing hands, there exists a few noteworthy hedge fund managers who were boosting their stakes substantially.

Of the funds we track, Visium Asset Management, managed by Jacob Gottlieb, holds the largest position in ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS). Visium Asset Management has a $17.6 million position in the stock, comprising 0.5% of its 13F portfolio. Sitting at the No. 2 spot is Millennium Management, managed by Israel Englander, which held a $11.9 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Some other hedge funds that are bullish include Joseph Edelman’s Perceptive Advisors, SAC Subsidiary’s Sigma Capital Management and Louis Bacon’s Moore Global Investments.

As aggregate interest increased, key hedge funds were breaking ground themselves. Visium Asset Management, managed by Jacob Gottlieb, assembled the biggest position in ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS). Visium Asset Management had 17.6 million invested in the company at the end of the quarter. Israel Englander’s Millennium Management also made a $11.9 million investment in the stock during the quarter. The other funds with new positions in the stock are Joseph Edelman’s Perceptive Advisors, SAC Subsidiary’s Sigma Capital Management, and Louis Bacon’s Moore Global Investments.

What do corporate executives and insiders think about ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)?

Insider buying is most useful when the company in question has seen transactions within the past six months. Over the last six-month time period, ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) has experienced zero unique insiders buying, and 8 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS). These stocks are United Therapeutics Corporation (NASDAQ:UTHR), Cubist Pharmaceuticals Inc (NASDAQ:CBST), Amarin Corporation plc (ADR) (NASDAQ:AMRN), Taro Pharmaceutical Industries Ltd. (NYSE:TARO), and The Medicines Company (NASDAQ:MDCO). This group of stocks are the members of the drug manufacturers – other industry and their market caps resemble ISIS’s market cap.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!